BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 11:47:00 AM | Browse: 324 | Download: 385
Publication Name World Journal of Gastroenterology
Manuscript ID 4575
Country of Manuscript Source Israel
Received
2013-07-08 09:47
Peer-Review Started
2013-07-08 14:25
To Make the First Decision
2013-08-08 11:19
Return for Revision
2013-08-19 21:05
Revised
2013-09-03 16:33
Second Decision
2013-09-16 17:36
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-17 06:34
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-01-06 09:51
Publish the Manuscript Online
2014-02-19 16:57
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Case Report
Article Title Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease
Manuscript Source Invited Manuscript
All Author List Elchanan Nussinson, Fahmi Shibli, Azmi Shahbari, Wasseem Rock, Mazen Elias and Irit Elmalah
Funding Agency and Grant Number
Corresponding author Elchanan Nussinson, MD, Gastroenterology Institute, Emek Medical Center, Duchifat 7 st’, Afula 18101, Israel. elchanann@gmail.com
Keywords Inflammatory bowel disease; Lymphoma; Primary effusion lymphoma; Primary effusion lymphoma-like lymphoma; Immunosuppressive therapy
Core Tip We report a case of primary effusion lymphoma (PEL)-like lymphoma in an elderly, male inflammatory bowel disease (IBD) patient on 6-mercaptopurine (6-MP) treatment. This rare lymphoma subtype is localized to serous body cavities without tumor mass formation or nodal involvement, and has been previously reported in individuals with hepatitis C virus or Epstein-Barr virus infection, in patients who underwent organ transplantation, and elderly patients This novel case in an IBD patient illustrates the importance of considering PEL-like lymphoma in IBD patients treated with 6-MP and anti-tumor necrosis factor antibodies who subsequently develop serous body cavity effusion.
Publish Date 2014-02-19 16:57
Citation Nussinson E, Shibli F, Shahbari A, Rock W, Elias M, Elmalah I. Primary effusion lymphoma-like lymphoma in a patient with inflammatory bowel disease. World J Gastroenterol 2014; 20(3): 857-862
Url http://www.wjgnet.com/1007-9327/full/v20/i3/857.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i3.857
Full Article (PDF) WJG-20-857.pdf
Full Article (Word) WJG-20-857.doc
Manuscript File 4575-Review.doc
Answering Reviewers 4575-Answering reviewers.pdf
Copyright License Agreement 4575-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 4575-Language certificate.pdf
Peer-review Report 4575-Peer reviewer(s).pdf
Scientific Editor Work List 4575-Scientific editor work list.doc